Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…of standard fertility-sparing treatment for EC and AH alongside tirzepatide. The primary outcomes include the reversal rate and time to rem…
…-specific CAR-T cells, generated in vivo from human PBMCs using AVO-100, control Raji tumor growth (A), improve mouse survival (B) and …
…ma (51.8%; n=73), non-small cell lung cancer (16.3%; n=23), and renal cell carcinoma (6.4%; n=9). Our result showed a significant difference between…
… DP1, has recently been proposed to play pro-tumoral functions. OKN4395 is a novel small molecule, highly selective and potent against …
…cell shape assessment of FRCs isolated directly from stage IIIC melanoma patients, showing consistent stretching compared to healthy cou…
…gimen start.Results Of 46 evaluable patients, 24 (52%) received ICI monotherapy and 22 (48%) received ICI-based combinations. Six p…
…erformed clinical validations in triple-negative breast cancer, non-small cell lung cancer, colorectal cancer, and other tumor types. In this study, we ev…
…lunteers. Animal experiments related to CAR-NK cell therapy for hepatocellular carcinoma were approved by the Institutional Animal Care and Use Committe…
…lis NJ. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. New England Journal of Medicine. 2023 Mar 16;388(11):1002-14.V…
…TILs) has shown remarkable and durable anti-tumour responses in metastatic melanoma, even in patients unresponsive to immune checkpoint inhibitors.…
…g immunosuppressive regimens comprising various combinations of sirolimus, everolimus, prednisone, cellcept, cyclosporine, tacrolimus, be…
…ty in treatment-refractory advanced cutaneous melanoma (CM) and synovial sarcoma (SS); there are opportunities to further improve outcomes in th…